Detalhe da pesquisa
1.
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
J Antimicrob Chemother
; 78(9): 2254-2262, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527369
2.
Comparative bactericidal activity of representative ß-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
J Antimicrob Chemother
; 77(5): 1306-1312, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137096
3.
Frontline antibiotic therapy.
Clin Med (Lond)
; 13(3): 263-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760700
4.
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy.
Breathe (Sheff)
; 15(4): 296-304, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31803264
5.
Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care.
Microb Drug Resist
; 28(5): 611-612, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35099290
6.
The dynamics of procalcitonin in COVID-19 patients admitted to Intensive care unit - a multi-centre cohort study in the South West of England, UK.
J Infect
; 82(6): e24-e26, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745917